ArticleJournal of hepatology2017

Cyclosporin derivatives inhibit hepatitis B virus entry without interfering with NTCP transporter activity.

Satomi Shimura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.